ImpactOS
See an example

Astellas Pharma Europe Limited

Companies and groups · United Kingdom

In these lists: Medicines

Declared lobbying cost
€500,000 – €599,999 Financial year 01/2024-12/2024
Commission meetings
5
Full-time staff on EU lobbying
1
European Parliament access passes
0
Registered since
24 Sept 2015
Public records onlyWhat this means

Every profile, record and figure comes from documents published by EU institutions, national authorities, courts, ethics bodies, the EU Transparency Register or established news outlets. We use no leaks, private data or anonymous tips. AI helps us gather and cross-check sources but never decides anyone's guilt: each record keeps its exact legal status and links to its source, so you can check it yourself

Registering is a legal transparency duty, not a sign of wrongdoing. Budgets and meetings show access, not influence on any particular decision. Register figures as declared on 30 Jun 2026

Fields of interest

Business and industry, Competition, Consumers, Customs, Digital economy and society, Economy, finance and the euro, Employment and social affairs, Enlargement, Environment, External relations, Institutional affairs, International co-operation and development, Public health, Regional policy, Research and innovation, Taxation, Trade

Medicines and food topics they name

EU medicines law, Critical medicines, Health technology assessment

EU laws and policies they declare following15
  • Free Trade Agreements - EU/US, EU/UK,
  • EU Beating Cancer Plan,
  • REACH revision,
  • Industrial strategy,
  • Competition Compass,
  • Horizon Europe,
  • Innovative Health Initiative (IHI),
  • Clinical Trials Regulation,
  • Community code related to medicinal products for human use in mainly countries that are part of the European Union - General Pharma Legislation proposal,
  • EU HTA Regulation
  • EMA consultations including on PFAs and TiO2
  • Biotech Act consultation,
  • Critical Medicines Act
  • EU4Health program
  • EU Plan for Rare Diseases

Meetings with the Commission

Meetings with Commissioners or their Cabinets since 1 December 2024, as the Commission publishes them

  1. With the Cabinet

    Roxana Mînzatu

    Women’s health, menopause, gender equality

    Published record
  2. With the Commissioner

    Stéphane Séjourné

    Compétitivité, Simplification

    Published record
  3. With the Cabinet

    Stéphane Séjourné

    Compétitivité, Simplification

    Published record
  4. With the Commissioner

    Stéphane Séjourné

    - Marché intérieur - Compétitivité - Sécurité économique - Simplification - Relation USA / Europe

    Published record
  5. With the Cabinet

    Stéphane Séjourné

    - Marché intérieur - Compétitivité - Sécurité économique - Simplification - Relation USA / Europe

    Published record

Official entries

Checked against sources on 11 Nov 2026